Routine I standing surely enhances the volume of complexity for virtually any investigation study. One example is, all scientists—irrespective of whether preclinical or medical—need to receive Plan I study registrations. 21 CFR portion 1301.18. By contrast, researchers who may have DEA Practitioner registrations in Schedules II–V (which most